Clinical Trial Update: Patient-controlled Versus Anesthesiologist-controlled Propofol-remifentanil in Awake Craniotomy [NA]

View source ↗

Summary

The trial comparing patient-controlled versus anesthesiologist-controlled propofol-remifentanil during awake craniotomy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Neoplasms

Drugs mentioned

• PROPOFOL (Propofol)
• Remifentanil (remifentanil)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Awake Craniotomy for Brain Tumour Surgery | NA | Status: WITHDRAWN